Markus Jerling
Chief Tech/Sci/R&D Officer at ONCOZENGE AB
Profile
Markus Jerling currently holds three positions as Chief Medical Officer at Kancera AB, OncoZenge AB, and Chief Medical & Business Officer at Diamyd Medical AB.
Previously, he worked as Director-Drug Safety at Pharmacia Corp., Vice President-Clinical Research at CV Therapeutics, Inc., and Chief Medical Officer at Newron Sweden AB.
He also worked as a Principal at Astra Arcus AB.
Dr. Jerling received a doctorate degree from Karolinska Institutet.
Markus Jerling active positions
| Companies | Position | Start |
|---|---|---|
| ONCOZENGE AB | Chief Tech/Sci/R&D Officer | 30/04/2021 |
| KANCERA AB | Chief Tech/Sci/R&D Officer | 31/08/2023 |
| DIAMYD MEDICAL AB | Chief Tech/Sci/R&D Officer | - |
Former positions of Markus Jerling
| Companies | Position | End |
|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Chief Tech/Sci/R&D Officer | 31/12/2003 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 31/12/1999 |
| Astra Arcus AB | Corporate Officer/Principal | 31/12/1997 |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Chief Tech/Sci/R&D Officer | - |
Training of Markus Jerling
| Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| KANCERA AB | Health Technology |
| DIAMYD MEDICAL AB | Health Technology |
| ONCOZENGE AB | Health Technology |
| Private companies | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
| Astra Arcus AB |
- Stock Market
- Insiders
- Markus Jerling
